TP53 and breast carcinoma: In order to induce the neoplastic transformation of these cells CRISPR/Cas9 for targeted knock-out of four breast cancer-associated tumor suppressors, such as P53, PTEN, RB1 and NF1 in mammary progenitor cells was used [485].